Updated on 2025/06/09

Information

 

写真a

 
Oi Keiji
 
Organization
Faculty of Medical Sciences Department of Clinical Medicine Assistant Professor
Kyushu University Hospital Angiocardiology(Concurrent)
School of Medicine Department of Medicine(Concurrent)
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926425360
Profile
九州大学病院循環器内科における臨床(心臓カテーテル主任)、教育(レジデント、研修医、学生の指導)

Research Areas

  • Life Science / Cardiology

Degree

  • Ph.D. ( 2005.3 Kyushu University )

Research History

  • Kyushu University Faculty of Medical Sciences Department of Clinical Medicine  Assistant Professor 

    2025.4 - Present

Education

  • Kyushu University    

    2002.4 - 2005.3

      More details

    Country:Japan

  • Saga Medical School   医学部   医学科

    1993.4 - 1999.3

      More details

    Country:Japan

Research Interests・Research Keywords

  • Research theme: Efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)

    Keyword: pulmonary hypertension

    Research period: 2014.4 - 2017.3

  • Research theme: A new method for diagnosis of myocardial ischemia by rest myocardial perfusion imaging using cardiac MDCT

    Keyword: ischemic heart disease, CT, diagnosis

    Research period: 2011.6 - 2014.3

Papers

  • Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial

    Nakano Yasuhiro, Yamamoto Mitsutaka, Matoba Tetsuya, Katsuki Shunsuke, Nakashiro Soichi, Takase Susumu, Akiyama Yusuke, Nagata Takuya, Mukai Yasushi, Inoue Shujiro, Oi Keiji, Higo Taiki, Takemoto Masao, Suematsu Nobuhiro, Eshima Kenichi, Miyata Kenji, Usui Makoto, Sadamatsu Kenji, Kadokami Toshiaki, Hironaga Kiyoshi, Ichi Ikuyo, Todaka Koji, Kishimoto Junji, Tsutsui Hiroyuki

    Journal of Atherosclerosis and Thrombosis   30 ( 8 )   907 - 918   2023.8   ISSN:13403478 eISSN:18803873

     More details

    Language:English   Publisher:Japan Atherosclerosis Society  

    <p> <b>Aim:</b> Several clinical trials using intravascular ultrasound (IVUS) evaluation have demonstrated that intensive lipid-lowering therapy by statin or a combination therapy with statin and ezetimibe results in significant regression of coronary plaque volume. However, it remains unclear whether adding ezetimibe to statin therapy affects coronary plaque composition and the molecular mechanisms of plaque regression. We conducted this prospective IVUS analysis in a subgroup from the CuVIC trial.</p><p><b>Methods:</b> The CuVIC trial was a prospective randomized, open, blinded-endpoint trial conducted among 11 cardiovascular centers, where 260 patients with coronary artery disease who received coronary stenting were randomly allocated into either the statin group (S) or the combined statin and ezetimibe group (S+E). We enrolled 79 patients (S group, 39 patients; S+E group, 40 patients) in this substudy, for whom serial IVUS images of nonculprit lesion were available at both baseline and after 6–8 months of follow-up.</p><p><b>Results:</b> After the treatment period, the S+E group had significantly lower level of low-density lipoprotein cholesterol (LDL-C; 80.9±3.7 vs. 67.7±3.8 mg/dL, <i>p</i>=0.0143). Campesterol, a marker of cholesterol absorption, and oxysterols (β-epoxycholesterol, 4β-hydroxycholesterol, and 27-hydroxycholesterol) were also lower in the S+E group. IVUS analyses revealed greater plaque regression in the S+E group than in the S group (−6.14% vs. −1.18% for each group, <i>p</i>=0.042). It was noteworthy that the lowering of campesterol and 27-hydroxycholesterol, but not LDL-C, had a significant positive correlation with plaque regression.</p><p><b>Conclusions:</b> Compared with statin monotherapy, ezetimibe in combination with statin achieved significantly lower LDL-C, campesterol, and 27-hydroxycholesterol, which resulted in greater coronary plaque regression.</p>

    DOI: 10.5551/jat.63507

    Web of Science

    Scopus

    PubMed

    CiNii Research

  • スタチンおよびエゼチミブによる脂質低下療法中の血清オキシステロールと冠動脈プラーク退縮との関連性 CuVIC試験からの知見(Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial)

    Nakano Yasuhiro, Yamamoto Mitsutaka, Matoba Tetsuya, Katsuki Shunsuke, Nakashiro Soichi, Takase Susumu, Akiyama Yusuke, Nagata Takuya, Mukai Yasushi, Inoue Shujiro, Oi Keiji, Higo Taiki, Takemoto Masao, Suematsu Nobuhiro, Eshima Kenichi, Miyata Kenji, Usui Makoto, Sadamatsu Kenji, Kadokami Toshiaki, Hironaga Kiyoshi, Ichi Ikuyo, Todaka Koji, Kishimoto Junji, Tsutsui Hiroyuki

    Journal of Atherosclerosis and Thrombosis   30 ( 8 )   907 - 918   2023.8   ISSN:1340-3478

     More details

    Language:English   Publisher:(一社)日本動脈硬化学会  

    冠動脈ステント留置術を受けた冠動脈疾患の患者をスタチン(S)またはSとエゼチミブの併用(S+E)で治療するCuVIC試験から、治療前と6~8ヵ月追跡調査後の非責任病変の血管内超音波(IVUS)画像が得られた79症例(S群39名、S+E群40名)を抽出し解析した。治療期間後のS+E群のLDL-コレステロール(LDL-C)値はS群と比べて有意に低かった。S+E群ではコレステロール吸収のマーカーであるcampesterol、オキシステロール(β-epoxycholesterol、4β-hydroxycholesterol、27-hydroxycholesterol)も低かった。IVUS解析でS+E群のプラーク退縮率はS群と比べて大きかった。campesterolおよび27-hydroxycholesterolの低下はプラーク退縮と正相関し、LDL-Cの低下は相関しなかった。

  • Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis

    Akiyama, Y; Katsuki, S; Matoba, T; Nakano, Y; Takase, S; Nakashiro, S; Yamamoto, M; Mukai, Y; Inoue, S; Oi, K; Higo, T; Takemoto, M; Suematsu, N; Eshima, K; Miyata, K; Usui, M; Sadamatsu, K; Kadokami, T; Hironaga, K; Ichi, I; Todaka, K; Kishimoto, J; Tsutsui, H

    NUTRIENTS   15 ( 13 )   2023.7   eISSN:2072-6643

     More details

    Language:English   Publisher:Nutrients  

    Oxysterols have been implicated in the pathogenesis of cardiovascular diseases. Serum levels of oxysterols could be positively correlated with cholesterol absorption and synthesis. However, physiological regulation of various serum oxysterols is largely unknown. The aim of this study was to investigate the relationship between clinical factors and cholesterol metabolism markers, and identify oxysterols associated with cholesterol absorption and synthesis in patients with coronary artery disease. Subjects (n = 207) who underwent coronary stenting between 2011 and 2013 were studied cross-sectionally. We measured lipid profiles including serum oxysterols. As for the serum biomarkers of cholesterol synthesis and absorption, oxysterol levels were positively correlated with campesterol and lathosterol. Covariance structure analysis revealed that dyslipidemia and statin usage had a positive correlation with “cholesterol absorption”. Statin usage also had a positive correlation with “cholesterol synthesis”. Several oxysterols associated with cholesterol absorption and/or synthesis. In conclusion, we elucidated the potential clinical factors that may affect cholesterol metabolism, and the associations between various oxysterols with cholesterol absorption and/or synthesis in patients with coronary artery disease.

    DOI: 10.3390/nu15132997

    Web of Science

    Scopus

    PubMed

  • Severe mitral regurgitation in chronic adult T-cell leukemia/lymphoma with granulomatous valvular inflammation

    Sunagawa G., Kato S., Sukehiro Y., Minematsu N., Nagatomo D., Nozoe M., Oi K., Ohshima K., Suematsu N., Kubota T.

    Journal of Cardiology Cases   27 ( 4 )   137 - 140   2023.4

     More details

    Publisher:Journal of Cardiology Cases  

    Adult T-cell leukemia/lymphoma (ATLL) is a mature peripheral T-cell neoplasm caused by human T-cell leukemia virus type I (HTLV-1) infection. Besides the oncogenic property, HTLV-1 causes HTLV-1-associated myelopathy/tropical spastic paraparesis and certain inflammatory diseases via a complex host immune response to latent virus infection. Cardiac involvement of ATLL is rare, with the majority of cases being disclosed in postmortem autopsy in patients with advanced subtypes. We herein report the case of a 64-year-old female patient with indolent chronic ATLL with severe mitral regurgitation. Although the condition of ATLL was stable, dyspnea on exertion gradually progressed over the course of three years and echocardiography revealed marked thickening of the mitral valve. Finally, the patient experienced hemodynamic collapse with atrial fibrillation and underwent surgical valve replacement. The removed mitral valve was grossly edematous and swollen. A histological examination revealed a granulomatous reaction mimicking the active phase of rheumatic valvulitis, with the infiltration of ATLL cells that were immunohistochemically positive for CD3, CD4, FoxP3, HLA-DRα, and CCR4. The postoperative course was uneventful, with the exception that Sjögren's syndrome was noted. The history of rheumatic fever was unclear, and such unique valvular pathology was presumably related to autoimmune mechanisms associated with HTLV-1 infection. Learning objective: We report a case of chronic adult T-cell leukemia/lymphoma (ATLL) with isolated valvular infiltration with a unique histology of granulomatous reaction. Human T-cell leukemia virus type I infection may accelerate autoimmune reactions and cardiac inflammation, irrespective of indolent clinical subtype. Among ATLL cases, possible progression of valvular insufficiency and heart failure in patients with cardiac symptoms should be carefully evaluated.

    DOI: 10.1016/j.jccase.2022.12.001

    Scopus

  • Effects of Patient Background and Treatment Strategy on Clinical Outcomes After Coronary Intervention for Calcified Nodule Lesions

    Nozoe M, Nishioka S, Oi K, Suematsu N, Kubota T.

    Circulation Reports   2021.11

     More details

    Publisher:Circulation Reports  

  • Successful stent implantation for acute take-off left coronary artery stenosis

    Mori S, Nagata H, Sakamoto I, Oi K, Ohga S.

    Pediatrics International   61 ( 9 )   933 - 935   2019.9

     More details

    Language:English  

  • Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial

    Takase S, Matoba T, Nakashiro S, Mukai Y, Inoue S, Oi K, Higo T, Katsuki S, Takemoto M, Suematsu N, Eshima K, Miyata K, Yamamoto M, Usui M, Sadamatsu K, Satoh S, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Egashira K, Sunagawa K.

    Arteriosclerosis, Thrombosis, and Vascular Biology   37 ( 2 )   350 - 358   2017.2

  • Optical Frequency Domain Imaging of Covered Stent-Graft for Pulmonary Artery Pseudoaneurysm After Balloon Pulmonary Angioplasty

    Horimoto K, Abe K, Ohtani K, Takahara Y, Hosokawa K, Oi K, Mukai Y, Kubo T, Matoba T, Tsutsui H.

    JACC: Cardiovascular Interventions   9 ( 21 )   2255 - 2256   2016.11

  • Balloon pulmonary angioplasty-related complications and therapeutic strategy in patients with chronic thromboembolic pulmonary hypertension

    Hosokawa K, Abe K, Oi K, Mukai Y, Hirooka Y, Sunagawa K.

    International Journal of Cardiology   197   224 - 226   2015.10

  • Negative acute hemodynamic response to balloon pulmonary angioplasty does not predicate the long-term outcome in patients with chronic thromboembolic pulmonary hypertension

    Hosokawa K, Abe K, Oi K, Mukai Y, Hirooka Y, Sunagawa K.

    International Journal of Cardiology   188   81 - 83   2015.1

  • In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice

    Yasuda S, Ikuta K, Uwatoku T, Oi K, Abe K, Hyodo F, Yoshimitsu K, Sugimura K, Utsumi H, Katayama Y, Shimokawa H.

    Journal of Vascular Research   45 ( 2 )   123 - 128   2008.2

  • Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits

    Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, Shimokawa H.

    The Tohoku Journal of Experimental Medicine   214 ( 2 )   151 - 158   2008.2

     More details

    Authorship:Lead author  

  • Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs

    Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, Shimokawa H.

    Coronary Artery Disease   18 ( 5 )   397 - 404   2007.8

  • Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice

    Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, Kaibuchi K, Shimokawa H.

    Journal of Cardiovascular Pharmacology   48 ( 6 )   280 - 285   2006.12

  • Prostacyclin does not inhibit rho-kinase: an implication for the treatment of pulmonary hypertension

    Abe K, Morikawa K, Hizume T, Uwatoku T, Oi K, Seto M, Ikegaki I, Asano T, Kaibuchi K, Shimokawa H.

    Journal of Cardiovascular Pharmacology   45 ( 2 )   120 - 124   2005.2

  • Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo

    Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunagawa K.

    Circulation   110 ( 19 )   3055 - 3061   2004.11

  • Postprandial increase in plasma concentrations of remnant-like particles: an independent risk factor for restenosis after percutaneous coronary intervention

    Oi K, Shimokawa H, Hirakawa Y, Tashiro H, Nakaike R, Kozai T, Ohzono K, Yamamoto K, Koyanagi S, Okamatsu S, Tajimi T, Kikuchi Y, Takeshita A.

    Journal of Cardiovascular Pharmacology   44 ( 1 )   66 - 73   2004.7

     More details

    Authorship:Lead author  

  • Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase

    Oi K, Shimokawa H, Hiroki J, Uwatoku T, Abe K, Matsumoto Y, Nakajima Y, Nakajima K, Takeichi S, Takeshita A.

    Arteriosclerosis, Thrombosis, and Vascular Biology   24 ( 5 )   918 - 922   2004.5

     More details

    Authorship:Lead author  

  • Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

    Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A.

    Circulation Research   94 ( 3 )   385 - 393   2004.2

  • In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent

    Yamamoto T, Ikuta K, Oi K, Abe K, Uwatoku T, Hyodo F, Murata M, Shigetani N, Yoshimitsu K, Shimokawa H, Utsumi H, Katayama Y.

    Elsevier Bioorganic & Medicinal Chemistry Letters   14 ( 11 )   2787 - 2790   2004.1

  • Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms

    Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, Eto Y, Fukumoto Y, Nakamura K, Shibata Y, Matsuda T, Takeshita A, Shimokawa H

    Arteriosclerosis, Thrombosis, and Vascular Biology   24 ( 1 )   181 - 186   2004.1

  • First functionalized MRI contrast agent recognizing vascular lesions

    Yamamoto T, Ikuta K, Oi K, Abe K, Uwatoku T, Murata M, Shigetani N, Yoshimitsu K, Shimokawa H, Katayama Y.

    Analytical Sciences   20 ( 1 )   5 - 7   2004.1

  • Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats

    Uwatoku T, Shimokawa H, Abe K, Matsumoto Y, Hattori T, Oi K, Matsuda T, Kataoka K, Takeshita A.

    Circulation Research   92 ( 7 )   62 - 69   2003.4

▼display all

Presentations

  • CoreValveの構造特性により左冠動脈起始異常を有した高度大動脈弁狭窄症に対してTAVIが安全に施行可能であった一例

    大賀 泰寛, 大井 啓司, 高原 勇介, 日浅 謙一, 坂本 隆史, 筒井 裕之, 森山 祥平, 横山 拓, 有田 武史, 園田 拓道, 塩瀬 明

    第24回日本心血管インターベンション治療学会 九州沖縄地方会  2017.1 

     More details

    Event date: 2017.1

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • 当院におけるTAVI(SAPIEN XT)の初期成績 −経大腿, 経心尖アプローチの比較−

    大井 啓司, 日浅 謙一, 坂本 隆史, 向井 靖, 筒井 裕之, 横山 拓, 有田 武史, 小田代 敬太, 園田 拓道, 大石 恭久, 塩瀬 明

    第23回日本心血管インターベンション治療学会 九州沖縄地方会  2016.8 

     More details

    Event date: 2016.8

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • シースの挿入に難渋した左鎖骨下動脈アプローチのTAVI症例

    大井 啓司, 日浅 謙一, 向井 靖, 横山拓, 有田武史, 園田 拓道, 大石 恭久, 塩瀬 明

    第7回日本経カテーテル心臓弁治療学会学術集会JTVT2016  2016.8 

     More details

    Event date: 2016.8

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:大阪   Country:Japan  

  • カテーテルそしてチームで治す大動脈弁狭窄症 Invited

    大井 啓司

    第164回 北築ハートカンファレンス  2016.1 

     More details

    Event date: 2016.1

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  • 病変形態および血行動態による末梢型慢性血栓閉塞性肺高血圧に対するバルーン血管形成術の治療戦略

    大井 啓司, 細川和也, 阿部 弘太郎, 向井 靖, 坂本 一郎, 井上 修二朗, 的場 哲哉, 肥後 太基, 砂川 賢二

    第63回日本心臓病学会学術集会  2015.9 

     More details

    Event date: 2015.9

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:横浜   Country:Japan  

  • BPA strategy to minimize the complications based on the angiographic types and hemodynamics

    大井 啓司, 細川 和也, 阿部 弘太郎, 向井 靖, 坂本 一郎, 井上 修二朗, 的場 哲哉, 肥後 太基, 砂川 賢二

    第24回日本心血管インターベンション治療学会学術集会  2015.7 

     More details

    Event date: 2015.8 - 2016.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • Two cases of successful stent implantation for stenosis of graft-native coronary anastomosis after Bentall operation

    大井 啓司, 向井 靖, 坂本 一郎, 井上 修二朗, 的場 哲哉, 砂川 賢二

    第24回日本心血管インターベンション治療学会学術集会  2015.7 

     More details

    Event date: 2015.8 - 2016.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • 当院でのTAVI導入 : 現在までの短期成績

    大井 啓司

    QcVIC UCG and SHD  2015.6 

     More details

    Event date: 2015.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • BPA strategy to minimize the complications in patients with inoperable CTEPH International conference

    Keiji Oi, Abe Kohtaro, Inoue Shujiro, Yasushi Mukai, Tetsuya Matoba

    第1回 HAKATA Cardiovascular Conference  2015.5 

     More details

    Event date: 2015.5 - 2016.6

    Language:English  

    Venue:Fukuoka   Country:Japan  

  • TAVIにおける大動脈弁狭窄症と麻酔導入 Invited

    大井 啓司, 辛島 裕士

    The 32nd Live Demonstration in KOKURA  2015.5 

     More details

    Event date: 2015.5

    Language:Japanese  

    Venue:北九州   Country:Japan  

  • 経カテーテル大動脈弁留置術(TAVI)のインパクト Invited

    大井 啓司

    福博循環器ミーティング  2015.4 

     More details

    Event date: 2015.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡   Country:Japan  

  • BPAの治療戦略 —症例からの考察-

    大井 啓司, 細川和也, 阿部弘太郎, 向井靖, 砂川賢二

    ストラクチャークラブ・ジャパン ライブデモンストレーション2014  2014.11 

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:東京   Country:Japan  

  • FFRでdeferした病変でAMIを発症した症例

    大井 啓司

    第18回SPIC研究会  2014.6 

     More details

    Language:Japanese  

    Country:Japan  

  • 慢性血栓塞栓性肺高血圧症の最新治療(バルーン肺動脈形成術)

    大井 啓司

    第250回 福岡心臓疾患治療談話会  2012.9 

     More details

    Language:Japanese  

    Country:Japan  

  • 左冠動脈優位の石灰化を伴うLCX入口部病変にPCIを行った症例.

    大井 啓司

    第6回九州Cardiovascular Intervention Conference : 6th QcVIC  2012.9 

     More details

    Language:Japanese  

    Country:Japan  

  • 虚血性心筋症に伴うVF stormに対してカテーテルアブレーションが有効であった一症例

    大井 啓司, 向井 靖, 細野彩良, 大賀泰寛, 井上 修二朗, 竹本真生, 砂川賢二

    第24回 カテーテル・アブレーション委員会公開研究会  2012.11 

     More details

    Language:Japanese  

    Country:Japan  

  • 悩ましいSeg6 just proximal lesionの仕上げ

    大井 啓司

    第7回九州Cardiovascular Intervention Conference : 7th QcVIC  2013.2 

     More details

    Language:Japanese  

    Country:Japan  

  • 経カテーテル的大動脈弁置換術(TAVR)に向けた九大病院ハートチームの取組み

    大井 啓司

    第9回西日本心臓血管研究会  2013.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:福岡市   Country:Japan  

  • 重症大動脈弁狭窄に対する最新治療 —経カテーテル大動脈弁植込み術ー

    大井 啓司

    循環器疾患最新治療病診連携の会  2013.8 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  • 多量の血栓の処理に苦慮した塞栓性急性下壁心筋梗塞の一例

    大井 啓司, 井上 修二朗, 向井 靖, 竹本 真生, 砂川 賢二

    第20回 日本心血管インターベンション治療学会 九州・沖縄地方会  2013.8 

     More details

    Language:Japanese  

    Venue:久留米市   Country:Japan  

  • 冠動脈ステント留置術後患者におけるエゼミチブの位置づけ

    大井 啓司, 的場 哲哉, 向井 靖, 竹本 真生, 砂川 賢二

    第11回New year循環器セミナー  2014.1 

     More details

    Language:Japanese  

    Country:Japan  

  • いよいよやってきたTAVI

    大井 啓司

    第9回九州Cardiovascular Intervention Conference : 9th QcVIC  2014.3 

     More details

    Language:Japanese  

    Country:Japan  

  • 心房細動に伴う心原性塞栓による心筋梗塞

    大井 啓司

    循環器エンボリズムカンファレンス  2014.4 

     More details

    Language:Japanese  

    Venue:福岡市   Country:Japan  

  • 重症石灰化病変におけるCardiac Shockwave Therapyの初期経験(Early Experience of Cardiac Shockwave Therapy in Severely Calcified Lesions)

    中城 総一, 山本 駿, 稲田 悠希, 倉岡 沙耶菜, 三宅 諒, 内川 智貴, 石北 陽仁, 巷岡 聡, 萬納寺 洋士, 権藤 公樹, 長友 大輔, 野副 純世, 大井 啓司, 末松 延裕, 久保田 徹

    日本循環器学会学術集会抄録集  2024.3  (一社)日本循環器学会

     More details

    Language:English  

  • 石灰化結節に対するPCIと患者背景

    野副 純世, 堤 孝樹, 大井 啓司, 末松 延裕, 久保田 徹

    日本心血管インターベンション治療学会抄録集  2022.7  (一社)日本心血管インターベンション治療学会

     More details

    Language:English  

  • 心不全・脳卒中予防のためのカテーテル治療講座 脳卒中予防のカテーテル治療

    大井 啓司

    日本心血管インターベンション治療学会抄録集  2023.8  (一社)日本心血管インターベンション治療学会

     More details

    Language:English  

  • 巨大Valsalva洞動脈瘤による左冠動脈主幹部心筋梗塞の1例

    溝上 玄龍, 久保田 徹, 末松 延裕, 大井 啓司, 野副 純世, 田中 敬士, 長友 大輔, 權藤 公樹, 巷岡 聡, 砂川 玄哉, 石北 陽仁, 内川 智貴, 安心院 法樹, 大西 菜月, 神殿 幸

    日本心血管インターベンション治療学会抄録集  2023.8  (一社)日本心血管インターベンション治療学会

     More details

    Language:English  

  • ヘパリン起因性血小板減少症を有する二尖弁大動脈弁狭窄症患者に対する術中アルガトロバン抗凝固療法を行う経カテーテル的大動脈弁置換術(Successful Transcatheter Aortic Valve Implantation Managed with Intraoperative Argatroban Anticoagulation in Patient with Bicuspid Aortic Valve Stenosis and Heparin-Induced Thrombocytopenia)

    Ajimi Tsuneki, Oi Keiji, Sukehiro Yuta, Tsujioka Satoshi, Shigemoto Eiji, Nagatomo Daisuke, Ohteki Madoka, Suematsu Nobuhiro, Minematsu Noritoshi, Kubota Toru

    日本循環器学会学術集会抄録集  2022.3  (一社)日本循環器学会

     More details

    Language:English  

  • IVUSガイドによる入口部ステント留置症例の検討

    西岡 真生, 太田 颯, 野副 純世, 大井 啓司, 末松 延裕

    日本心血管インターベンション治療学会抄録集  2024.7  (一社)日本心血管インターベンション治療学会

     More details

    Language:Japanese  

  • 当院における急性下肢虚血に対する外科的血行再建と血管内治療との比較検討

    内川 智貴, 末松 延裕, 山本 駿, 稲田 悠希, 倉岡 沙耶菜, 三宅 諒, 石北 陽仁, 巷岡 聡, 萬納寺 洋士, 權藤 公樹, 中城 総一, 長友 大輔, 野副 純世, 大井 啓司, 久保田 徹, 岡留 淳, 伊東 啓行

    日本心血管インターベンション治療学会抄録集  2024.7  (一社)日本心血管インターベンション治療学会

     More details

    Language:English  

  • 多職種心不全外来における、栄養摂取不良患者に対する栄養介入前後の食事摂取状況の変化について

    掛川 ちさと, 長友 大輔, 野元 大, 中原 さちこ, 権藤 公樹, 田中 敬士, 野副 純世, 大井 啓司, 末松 延裕, 熊本 チエ子, 久保田 徹

    日本循環器学会学術集会抄録集  2023.3  (一社)日本循環器学会

     More details

    Language:Japanese  

▼display all

MISC

  • 高レムナントリポ蛋白血症と冠動脈形成術後狭窄.

    大井啓司、下川宏明

    循環器科. 55巻: 65-70, 2004.   2004.1

Professional Memberships

  • 日本内科学会

  • 日本循環器学会

  • 日本心血管インターベンション治療学会

  • 日本経カテーテル心臓弁治療学会

Class subject

  • 医歯薬合同講義 循環器概論(臨床医学Ⅲ-①)

    2017.4 - 2018.3   Full year

  • 臨床医学群 循環器学

    2016.10 - 2017.3   Second semester

  • 保健学科生理検査学

    2016.4 - 2016.9   First semester

  • 臨床医学群 循環器学

    2015.10 - 2016.3   Second semester

  • 保健学科生理検査学

    2015.4 - 2015.9   First semester

  • 臨床医学群3年生 循環器学

    2014.10 - 2015.3   Second semester

  • 保健学科検査 選考3年生 生理検査

    2014.4 - 2014.9   First semester

  • 臨床医学群 3年生 循環器学

    2013.10 - 2014.3   Second semester

  • 保健学科検査 専攻3年生 生理検査

    2013.4 - 2013.9   First semester

  • 循環器内科学

    2012.10 - 2013.3   Second semester

  • 保健学科検査先攻3年生 心臓カテーテル検査・治療

    2012.4 - 2012.9   First semester

  • 保健学科検査先攻3年生 心臓カテーテル検査・治療

    2011.4 - 2011.9   First semester

▼display all

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Internal Medicine / Cardiology

Clinician qualification

  • Specialist

    The Japanese Society of Internal Medicine(JSIM)

  • Specialist

    The Japanese Circulation Society(JCS)

  • Specialist

    日本心血管インターベンション治療学会

  • Preceptor

    経カテーテル的心臓弁治療関連学会

Year of medical license acquisition

  • 1999

Notable Clinical Activities

  • 経カテーテル的大動脈弁置換術の指導医、心血管インターベンションの専門医として、カテーテル治療に従事している。